StockNews.com Upgrades Phibro Animal Health (NASDAQ:PAHC) to Strong-Buy

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a buy rating to a strong-buy rating in a report released on Wednesday morning.

Several other analysts have also commented on PAHC. Barclays increased their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Morgan Stanley increased their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Stock Performance

PAHC opened at $21.90 on Wednesday. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The company has a market capitalization of $886.95 million, a price-to-earnings ratio of 50.93, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53. The business has a 50 day moving average price of $22.08 and a two-hundred day moving average price of $21.48. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, November 6th. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.12. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. The business had revenue of $260.40 million during the quarter, compared to analysts’ expectations of $277.76 million. During the same quarter last year, the business posted $0.14 earnings per share. Research analysts predict that Phibro Animal Health will post 1.62 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.19%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 111.63%.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds have recently made changes to their positions in the company. nVerses Capital LLC purchased a new position in Phibro Animal Health during the 3rd quarter worth approximately $70,000. Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health in the third quarter worth $70,000. China Universal Asset Management Co. Ltd. grew its holdings in shares of Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after buying an additional 1,522 shares in the last quarter. CWM LLC raised its position in Phibro Animal Health by 190.8% during the third quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after buying an additional 4,175 shares during the period. Finally, Algert Global LLC purchased a new stake in Phibro Animal Health in the 2nd quarter worth about $193,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.